CRISPR Therapeutics AG Quarterly Marketable Securities, Current in USD from Q4 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
CRISPR Therapeutics AG quarterly Marketable Securities, Current history and growth rate from Q4 2019 to Q2 2024.
  • CRISPR Therapeutics AG Marketable Securities, Current for the quarter ending June 30, 2024 was $1.52B, a 14.6% increase year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $1.52B +$194M +14.6% Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $1.4B -$138M -8.97% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $1.3B -$299M -18.7% Dec 31, 2023 10-Q 2024-08-05
Q3 2023 $1.21B -$190M -13.5% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $1.32B -$245M -15.6% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $1.54B +$1.41M +0.09% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $1.6B +$147M +10.1% Dec 31, 2022 10-K 2024-02-21
Q3 2022 $1.4B -$64M -4.37% Sep 30, 2022 10-Q 2022-11-01
Q2 2022 $1.57B +$626M +66.4% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $1.54B +$857M +126% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $1.46B +$934M +179% Dec 31, 2021 10-K 2023-02-21
Q3 2021 $1.47B +$1.14B +352% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $943M Jun 30, 2021 10-Q 2021-07-29
Q1 2021 $680M Mar 31, 2021 10-Q 2021-04-27
Q4 2020 $522M +$522M Dec 31, 2020 10-K 2022-02-15
Q3 2020 $325M Sep 30, 2020 10-Q 2020-10-28
Q4 2019 $0 Dec 31, 2019 10-K 2021-02-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.